» Articles » PMID: 21915647

The PPARγ Agonist Rosiglitazone Prevents Cognitive Impairment by Inhibiting Astrocyte Activation and Oxidative Stress Following Pilocarpine-induced Status Epilepticus

Overview
Journal Neurol Sci
Specialty Neurology
Date 2011 Sep 15
PMID 21915647
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Epilepsy is commonly associated with cognitive impairment. Astrocyte activation and oxidative stress occur following seizures, and play a role in the pathological injury of epilepsy with cognitive impairment. The peroxisome proliferator-activated receptor gamma (PPARγ) has been shown to exhibit neuroprotective and antioxidative effects in CNS diseases. Thus, we hypothesized that rosiglitazone, a PPARγ agonist, would prevent cognitive impairment by inhibiting astrocyte activation and regulating glutathione (GSH) homeostasis after status epilepticus (SE). Using a lithium pilocarpine-induced SE model, we found that rosiglitazone significantly prevented cognitive impairment induced by SE, and potently inhibited astrocyte activation with maintenance of GSH homeostasis in the hippocampus after SE. These protective effects were significantly reversed by co-treatment with the PPARγ antagonist T0070907. These data suggest that rosiglitazone can improve cognitive impairment, and inhibit astrocyte activation and oxidative damage following SE. Rosiglitazone may be a promising agent for treatment of epilepsy involving SE-induced cognitive impairment.

Citing Articles

Therapeutic modulation of JAK-STAT, mTOR, and PPAR-γ signaling in neurological dysfunctions.

Kumar S, Mehan S, Narula A J Mol Med (Berl). 2022; 101(1-2):9-49.

PMID: 36478124 DOI: 10.1007/s00109-022-02272-6.


N-Methyl-(2S, 4R)-trans-4-hydroxy-L-proline, the major bioactive compound from Sideroxylon obtusifolium, attenuates pilocarpine-induced injury in cultured astrocytes.

Aquino P, Siqueira E, Paes L, Magalhaes E, Barbosa T, Carvalho M Braz J Med Biol Res. 2022; 55:e12381.

PMID: 36350974 PMC: 9635815. DOI: 10.1590/1414-431X2022e12381.


Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement.

Sharma S, Shen T, Chitranshi N, Gupta V, Basavarajappa D, Sarkar S Mol Neurobiol. 2022; 59(4):2027-2050.

PMID: 35015251 PMC: 9015987. DOI: 10.1007/s12035-021-02709-y.


Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy.

Ramandi D, Elahdadi Salmani M, Moghimi A, Lashkarbolouki T, Fereidoni M PLoS One. 2021; 16(1):e0246068.

PMID: 33507976 PMC: 7842975. DOI: 10.1371/journal.pone.0246068.


Rosiglitazone polarizes microglia and protects against pilocarpine-induced status epilepticus.

Peng J, Wang K, Xiang W, Li Y, Hao Y, Guan Y CNS Neurosci Ther. 2019; 25(12):1363-1372.

PMID: 31729170 PMC: 6887926. DOI: 10.1111/cns.13265.


References
1.
Uryu S, Harada J, Hisamoto M, Oda T . Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons. Brain Res. 2001; 924(2):229-36. DOI: 10.1016/s0006-8993(01)03242-5. View

2.
Abe K, Nakanishi K, Saito H . The possible role of endogenous glutathione as an anticonvulsant in mice. Brain Res. 2000; 854(1-2):235-8. DOI: 10.1016/s0006-8993(99)02269-6. View

3.
Elsharkawy A, Alabbasi A, Pannek H, Oppel F, Schulz R, Hoppe M . Long-term outcome after temporal lobe epilepsy surgery in 434 consecutive adult patients. J Neurosurg. 2008; 110(6):1135-46. DOI: 10.3171/2008.6.JNS17613. View

4.
Pouzet B, Zhang W, Feldon J, Rawlins J . Hippocampal lesioned rats are able to learn a spatial position using non-spatial strategies. Behav Brain Res. 2002; 133(2):279-91. DOI: 10.1016/s0166-4328(02)00007-4. View

5.
Jiang Q, Heneka M, Landreth G . The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications. CNS Drugs. 2007; 22(1):1-14. DOI: 10.2165/00023210-200822010-00001. View